Novavax
NVAX
#5721
Rank
C$1.82 B
Marketcap
C$11.06
Share price
-3.02%
Change (1 day)
24.18%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): C-$2.13

According to Novavax's latest financial reports the company's current EPS (TTM) is C-$2.18. In 2025 the company made an earnings per share (EPS) of C$3.92 an increase over its 2024 EPS that were of C-$1.76.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$2.13-154.23%
2025C$3.92-322.76%
2024C-$1.76
2022C-$11.89-64.36%
2021C-$33.35243%
2020C-$9.7219.75%
2019C-$8.12-43.86%
2018C-$14.46-19.84%
2017C-$18.04-38.83%
2016C-$29.5074.58%
2015C-$16.9063.89%
2014C-$10.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.52-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.20-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$4.12-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C-$3.77 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.23 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$2.89-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C-$0.63-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C-$1.93-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$7.22 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA